The two most streamed movies in June were about the end of the world, but they offer wildly different takes on how it will go down. This month's top streamers indicate a collective subconscious that's ...

One of these movies is what you should watch tonight. There's original streaming fare like the John Cena comedy "Little Brother" and Oscar Isaac's "In the Hand of Dante." Catch up on theatrical ...

With the Minnesota Timberwolves moving on to the second round, they still have plenty of concerns in the injury department. Ayo Dosunmu is one name to keep an eye on, along with Anthony Edwards and ...

Trust Hulu to stream some of the hottest – and funniest – shows on TV right now. The streamer is debuting some of summer’s most highly anticipated series throughout July, and Watch With Us has ...

We can all use a little thrill in our lives. If you have Netflix, you’ll get plenty of them as the streamer is one of the best platforms around to watch quality film thrillers. That’s particularly ...

Shuji Nakamura already transformed the world once. His invention of blue light-emitting diodes (LEDs) changed everything about our daily lives. Computers, phones, big screens, traffic lights and ...

ST. LOUIS – If you are looking for adventure between the pages, check out the Lit Chick Book Club. The group celebrates books written by Black authors. Kara Watkins and Theresa Millen are here to tell ...

Mr. Hicklin, a bookstore owner, is a former editor in chief of Out magazine. Just over 10 years ago, I opened a small bookstore a few hours northwest of New York City. The shelves are arranged by ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred FX’s “The Bear” ends with its fifth and final ...

Legal-affairs journalist Paula Reid is expected to take up new duties at MS NOW, according to a person familiar with the matter, leaving behind a top job at CNN in part due to the uncertainty of its ...

AbbVie struggled after its blockbuster autoimmune disease drug, Humira, lost its U.S. patent exclusivity in 2023. But it offset that pressure with two newer immunology drugs, Skyrizi and Rinvoq, which ...